Beryllium Bioavailability

Beryllium Bioavailability is the proportion of ingested or inhaled beryllium that is absorbed and becomes accessible for biological interaction within the body, distinguishing it from other measures of exposure by specifically quantifying the fraction that enters systemic circulation and can potentially induce toxicological effects.

14

Publications

376

Citations

43

Authors

30

Institutions

Publications per year

2017–2026

4

Authors

43

  1. MD
    Mark D. Hoover

    National Institute for Occupational Safety and Health, United States

    2 publications · 77 citations

    2

    h-index

  2. GL
    Gregory L. Finch

    Lovelace Respiratory Research Institute, United States

    2 publications · 79 citations

    2

    h-index

  3. LK
    Larisa Kybarskaya

    Institute of Experimental Medicine, Russia

    1 publications · 25 citations

    1

    h-index

  4. SD
    Sergey Dagaev

    St Petersburg University, Russia

    1 publications · 25 citations

    1

    h-index

  5. KC
    K. C. Pillai

    Bhabha Atomic Research Centre, India

    1 publications · 13 citations

    1

    h-index

1–5 of 43

Venues

  1. Human Toxicology

    1 publications · 32 citations

    1

    h-index

  2. Geochimica et Cosmochimica Acta

    1 publications · 23 citations

    1

    h-index

  3. Chemical Research in Toxicology

    1 publications · 33 citations

    1

    h-index

  4. Journal of Hazardous Materials

    1 publications · 39 citations

    1

    h-index

  5. Chemico-Biological Interactions

    1 publications · 26 citations

    1

    h-index

1–5